Catheter ablation in atrial fibrillation
Authors:
Petr Peichl; Robert Čihák; Dan Wichterle; Josef Kautzner
Authors place of work:
Institut klinické a experimentální medicíny Praha, Klinika kardiologie
Published in the journal:
Čas. Lék. čes. 2011; 150: 14-19
Category:
Review Article
Summary
During the last years catheter ablation has become the treatment of choice for patients with paroxysmal or persistent atrial fibrillation that is symptomatic and resistant to pharmacologic therapy. The cornerstone of the procedure is complete electrical isolation of pulmonary veins that is achieved by creation of series of lesions in the pulmonary vein adjancent atrial tissue. In patients with persistent or permanent atrial fibrillation the isolation is accompanied by more extensive modification of arrhythmogenic substrate within the atria. The success rate in prevention of recurrences of atrial fibrillation ranges between 70–90%. Despite the significant progress catheter ablation of atrial fibrillation remains a complex procedure that is associated with the risk of severe complications.
Key words:
atrial fibrillation, catheter ablation.
Zdroje
1. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31(19): 2369–2429.
2. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation. Circulation 2006; 114(7): e257–e354.
3. Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, et al. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study. Circulation 2004; 109(12): 1509–1513.
4. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339(10): 659–666.
5. Pappone C, Rosanio S, Oreto G, Tocchi M, Gugliotta F, Vicedomini G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000; 102(21): 2619–2628.
6. Oral H, Scharf C, Chugh A, Hall B, Cheung P, Good E, et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 2003; 108(19): 2355–2360.
7. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008; 118(24): 2498–2505.
8. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F, Jr., et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354(9): 934–941.
9. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48(11): 2340–2347.
10. Stabile G, Bertaglia E, Senatore G, De SA, Zoppo F, Donnici G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006; 27(2): 216–221.
11. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace 2007; 9(6): 335–379.
12. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293(21): 2634–2640.
13. Hsu LF, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351(23): 2373–2383.
14. Arya A, Piorkowski C, Sommer P, Bollmann A, Hindricks G. Ablation of atrial fibrillation: patient selection, techniques, and the results. Herzschrittmacherther Elektrophysiol 2008; 19(2): 68–72.
15. Traub D, Daubert JP, McNitt S, Zareba W, Hall B. Catheter ablation of atrial fibrillation in the elderly: where do we stand? Cardiol J 2009; 16(2): 113–120.
16. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111(9): 1100–1105.
17. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3(1): 32–38.
18. Peichl P, Mlčochova H, Čihák R, Kautzner J. Selektivní katetrizační ablace fibrilace síní: potenciální komplikace výkonu a možnosti jejich prevence. Interv Akut Kardiol 2008; 7: 226–229.
19. Raviele A, Themistoclakis S, Rossillo A, Bonso A. Iatrogenic postatrial fibrillation ablation left atrial tachycardia/flutter: how to prevent and treat it? J Cardiovasc Electrophysiol 2005; 16(3): 298–301.
20. Mesas CE, Pappone C, Lang CC, Gugliotta F, Tomita T, Vicedomini G, et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: electroanatomic characterization and treatment. J Am Coll Cardiol 2004; 44(5): 1071–1079.
21. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104(24): 2886–2891.
22. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285(22): 2864–2870.
23. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor–based approach: the euro heart survey on atrial fibrillation. Chest 2010; 137(2): 263–272.
24. Sawhney N, Anousheh R, Chen WC, Narayan S, Feld GK. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol 2009; 104(3): 366–372.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Metamizole vs. Tramadol in Postoperative Analgesia
- Spasmolytic Effect of Metamizole
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
Najčítanejšie v tomto čísle
- Acute liver failure: Present recommendations
- Hyperglycemia and its control in the critically ill patient
- Kidney transplantation at the Institute for Clinical and Experimental Medicine
- Eversion carotid endarterectomy: evaluation of results after changing the operation technique